NEW ORLEANS ― At the American Academy of Ophthalmology meeting here, Nathan C. Steinle, MD, discusses the RADIANCE trial comparing Lucentis (ranibizumab, Genentech) vs. photodynamic therapy for myopic choroidal neovascular membrane.
This activity is supported by educational grants from Carl Zeiss Meditec, Inc. and Regeneron Pharmaceuticals, Inc.
American Academy of Optometry
Search Healio's robust listing of national and international medical meetings.
Tell us what you think about Healio.com »
©2017 Healio All Rights Reserved.